Maybe we are only in talks with Dios.
As I wrote in a somewhat-joking post earlier, "talks" could mean cold-calling a big pharma and asking if they wanted to license a drug. But I guess if they actually sign a confidentiality agreement, that means they have some interest.
So, yes, it would be nice if we would release such a list. But management won't, because they don't care about the stock price at all.